3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
HER2+ Metastatic Breast Cancer (MBC)
1
Interventions
zolbetuximab
2
Oxaliplatin
2
Afatinib
2
trastuzumab deruxtecan
1
tepotinib
1
repotrectinib
1
pralsetinib
1
brigatinib
1
Standard of Care
1
Pemetrexed
1
Leucovorin
1
Fluorouracil
1
Crizotinib
1
Cisplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has announcements
×
Adenocarcinoma
×
Lapatinib
×
Clear all
No trials found.